Citation: Lc. Young et al., Multidrug resistance proteins MRP3, MRP1, and MRP2 in lung cancer: Correlation of protein levels with drug response and messenger RNA levels, CLIN CANC R, 7(6), 2001, pp. 1798-1804
Authors:
Mirski, SEL
Voskoglou-Nomikos, T
Young, LC
Deeley, RG
Campling, BG
Gerlach, JH
Cole, SPC
Citation: Sel. Mirski et al., Simultaneous quantitation of topoisomerase II alpha and beta isoform mRNAsin lung tumor cells and normal and malignant lung tissue, LAB INV, 80(6), 2000, pp. 787-795
Authors:
Mirski, SEL
Sparks, KE
Yu, QA
Lang, AJ
Jain, N
Campling, BG
Cole, SPC
Citation: Sel. Mirski et al., A truncated cytoplasmic topoisomerase II alpha in a drug-resistant lung cancer cell line is encoded by a TOP2A allele with a partial deletion of exon34, INT J CANC, 85(4), 2000, pp. 534-539
Citation: Lc. Young et al., Expression of multidrug resistance protein-related genes in lung cancer: Correlation with drug response, CLIN CANC R, 5(3), 1999, pp. 673-680
Authors:
Tang, XX
Brodeur, GM
Campling, BG
Ikegaki, N
Citation: Xx. Tang et al., Coexpression of transcripts encoding EPHB receptor protein tyrosine kinases and their ephrin-B ligands in human small cell lung carcinoma, CLIN CANC R, 5(2), 1999, pp. 455-460